EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Tissue Engineering and Regenerative Medicine: Biomaterials, Biofabrication, Cell-Based and Cell-Free Therapies, and Applications in Reconstructive and Aesthetic Medicine

Caijun Jin iD, Zhiyuan Ding, Huizhen Ming, JungHee Shim, Vo Tien Huy, Pham Ngoc Chien iD, Kyung Min Choi, Chan Yeong Heo iD

Cells · 24.08.2026 · 15 (17) · 1518

DOI: 10.3390/cells15171518 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 24.08.2026. Verfasst von Caijun Jin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea. Hauptthemen laut MEDLINE: Regenerative Medicine, Tissue Engineering, Biocompatible Materials, Esthetics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 231 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tissue engineering and regenerative medicine are shifting from passive tissue replacement toward instructive platforms that regulate cellular behavior, immune responses, vascularization, and extracellular matrix remodeling. This review examines recent advances in natural, synthetic, composite, and stimuli-responsive biomaterials, biofabrication and 3D bioprinting, stem and progenitor cell therapies, extracellular vesicles and other cell-free products, immunomodulatory scaffolds, skin organoids and organ-on-a-chip systems, nanotechnology, and artificial intelligence-assisted design. Particular emphasis is placed on plastic, reconstructive, and aesthetic applications, including skin and wound repair, craniofacial bone and cartilage regeneration, peripheral nerve reconstruction, vascularization, and dental and periodontal repair. The review also considers biomodulators and skinboosters as emerging regenerative-aesthetic interventions that aim to improve dermal hydration, fibroblast activity, collagen remodeling, and skin quality rather than provide volume replacement alone. Importantly, these technologies differ substantially in translational maturity, ranging from in vitro and preclinical platforms to early clinical interventions, established clinical products, and commercially available treatments for which durable regenerative efficacy remains incompletely validated. Throughout this review, biological plausibility and preclinical efficacy are therefore distinguished from human clinical evidence, regulatory or established clinical use, and commercial availability. Progress will require standardized characterization, mechanism-linked potency assays, clinically relevant models, and outcome measures that capture functional integration, durability, safety, and aesthetic performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Regenerative MedicineTissue EngineeringBiocompatible MaterialsEstheticsHumansAnimalsTissue Scaffolds

Stichwörter der Autor:innen

3D bioprintingbiomaterialsbiomodulatorsextracellular matrixextracellular vesiclesregenerative medicineskin regenerationskinboostersstem cellstissue engineering

Substanzen

Biocompatible Materials

Autor:innen und Institutionen

  • Department of Plastic and Reconstructive Surgery, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.
  • Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea.
  • Department of Anatomy, VNU University of Medicine and Pharmacy, Vietnam National University, Hanoi 100000, Vietnam.
  • Department of Chemical and Biological Engineering, Sookmyung Women's University, Seoul 04310, Republic of Korea.
  • LabInCube Co. Ltd., Cheongju 28116, Republic of Korea.

ORCID-Profile: Caijun Jin, Pham Ngoc Chien, Chan Yeong Heo

Zitieren

APA

Jin, C., Ding, Z., Ming, H., Shim, J., Huy, V. T., Chien, P. N., Choi, K. M., & Heo, C. Y. (2026). Advances in Tissue Engineering and Regenerative Medicine: Biomaterials, Biofabrication, Cell-Based and Cell-Free Therapies, and Applications in Reconstructive and Aesthetic Medicine. Cells, 15(17), 1518. https://doi.org/10.3390/cells15171518

Vancouver

Jin C, Ding Z, Ming H, Shim J, Huy VT, Chien PN, et al. Advances in Tissue Engineering and Regenerative Medicine: Biomaterials, Biofabrication, Cell-Based and Cell-Free Therapies, and Applications in Reconstructive and Aesthetic Medicine. Cells. 2026;15(17):1518. doi:10.3390/cells15171518

BibTeX
@article{Jin2026,
  author = {Jin, Caijun and Ding, Zhiyuan and Ming, Huizhen and Shim, JungHee and Huy, Vo Tien and Chien, Pham Ngoc and Choi, Kyung Min and Heo, Chan Yeong},
  title = {Advances in Tissue Engineering and Regenerative Medicine: Biomaterials, Biofabrication, Cell-Based and Cell-Free Therapies, and Applications in Reconstructive and Aesthetic Medicine},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {17},
  pages = {1518},
  doi = {10.3390/cells15171518}
}
Kostenlos starten →